Novavax Inc NVAX
News
Novavax to Participate in BofA Securities 2024 Health Care Conference
Novavax Shares Pop Another 50% Following Sanofi Deal
Novavax shares more than double on Sanofi's $1.4 billion investment for combo vaccine
Trending: Sanofi, Novavax to Develop New Covid-19 Vaccines
Novavax Shares Surge on $1.4 Billion Vaccine Licensing Deal with Sanofi
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines
Novavax to Host Conference Call to Discuss First Quarter 2024 Financial Results and Operational Highlights on May 10, 2024
Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual Meeting
Novavax failed to capitalize on fears surrounding mRNA vaccines, activist investor says
Shah Capital nominates two highly qualified independent director candidates for Novavax
Novavax Presents Data on Updated COVID-19 Vaccine and Progress to Date on its COVID-19-Influenza Combination Vaccine Candidate at World Vaccine Congress 2024
Novavax to Participate in TD Cowen's 44th Annual Health Care Conference
Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Novavax and Gavi Reach Settlement on 2021 COVID-19 Vaccine Advance Purchase Agreement
Moderna Shares, Other Covid Vaccine Makers Hit by Warning From Pfizer
Novavax's stock pops after WHO grants its COVID-19 vaccine emergency-use listing
Novavax shares rise as third quarter results top expectations
Moderna confirms COVID sales guidance as shares sink on Pfizer news